FindTrial
Sign In

The role of different subgroups of myeloid-derived suppressor cells (MDSCs) in critically ill patients

The role of myeloid-derived suppressor cells (MDSCs) in critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079024
Enrollment
Unknown
Registered
2023-12-23
Start date
2023-12-27
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sepsis group:None
Non sepsis group:None

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age = 18 years old; Acute Physiology and Chronic Health Evaluation II (APACHE II) = 15 points; Agree to participate in this study.

Exclusion criteria

Exclusion criteria: Pregnant women, cancer patients, transplant patients, HIV infected individuals, or patients receiving immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
M-MDSCs;PMN-MDSCs;—

Secondary

MeasureTime frame
Lymphocyte subpopulation count;Regulatory T-cell;Cytokine;Arg-1;iNOS;—

Countries

China

Contacts

Public ContactLijing Jia

Hebei General Hospital

jlj011365@163.com+86 153 7382 9696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026